REFERENCES
1. Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801-10 (2016).
2. Giamarellos-Bourboulis, E. J. et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat. Immunol. 25, 19-28 (2024).
3. Huang, M.; Cai, S.; Su, J. The pathogenesis of sepsis and potential therapeutic targets. Int. J. Mol. Sci. 20, 5376 (2019).
4. Hotchkiss, R. S.; Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-50 (2003).
5. Jarczak, D.; Kluge, S.; Nierhaus, A. Sepsis - pathophysiology and therapeutic concepts. Front. Med. 8, 628302 (2021).
6. Gola, A. et al. Commensal-driven immune zonation of the liver promotes host defence. Nature 589, 131-6 (2021).
7. Hammerich, L.; Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20, 633-46 (2023).
8. Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-4 (2004).
9. Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127-35 (2010).
10. Gu, X. et al. New insights into iNKT cells and their roles in liver diseases. Front. Immunol. 13, 1035950 (2022).
11. Yao, T.; Maccioni, L.; Guan, Y.; Rodrigues, R. M.; Gao, B. Liver as a key organ for systemic antimicrobial defense. Hepatol. Commun. 9, e0814 (2025).
12. Li, D.; Wu, M. Pattern recognition receptors in health and diseases. Sig. Transduct. Target. Ther. 6, 291 (2021).
13. Xu, M. J. et al. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL‐6/STAT3. Hepatology 61, 692-702 (2015).
14. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819-26 (2007).
15. Ehlting, C.; Wolf, S. D.; Bode, J. G. Acute-phase protein synthesis: a key feature of innate immune functions of the liver. Biol. Chem. 402, 1129-45 (2021).
16. Bui, T. M.; Wiesolek, H. L.; Sumagin, R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J. Leukoc. Biol. 108, 787-99 (2020).
17. Gong, J.; Tu, W.; Liu, J.; Tian, D. Hepatocytes: a key role in liver inflammation. Front. Immunol. 13, 1083780 (2023).
18. Liu, L. et al. Hepatic IκBζ promotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-mediated neutrophil infiltration. Free Radic. Biol. Med. 237, 558-69 (2025).
19. Lajarin, F.; Rubio, G.; Lorenzo, N.; Gámiz, P.; Hernandez-Caselles, T.; Garcia-Peñarrubia, P. Implication of reactive oxygen species in the antibacterial activity against Salmonella Typhimurium of hepatocyte cell lines. Free Radic. Biol. Med. 27, 1008-18 (1999).
20. Cui, X.; Song, Y.; Han, J.; Yuan, Z. The multifaceted role of SMAD4 in immune cell function. Biochem. Biophys. Rep. 41, 101902 (2024).
21. Chen, W.; Ten Dijke, P. Immunoregulation by members of the TGFβ superfamily. Nat. Rev. Immunol. 16, 723-40 (2016).
22. Park, S. R.; Lee, J. H.; Kim, P. H. Smad3 and Smad4 mediate transforming growth factor-β1-induced IgA expression in murine B lymphocytes. Eur. J. Immunol. 31, 1706-15 (2001).
23. Pan, H.; Ding, E.; Hu, M.; Lagoo, A. S.; Datto, M. B.; Lagoo-Deenadayalan, S. A. SMAD4 is required for development of maximal endotoxin tolerance. J. Immunol. 184, 5502-9 (2010).
24. Hahn, J. N.; Falck, V. G.; Jirik, F. R. Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice. J. Clin. Invest 121, 4030-42 (2011).
25. Choi, S. H.; Huang, A. Y.; Letterio, J. J.; Kim, B. G. Smad4-deficient T cells promote colitis-associated colon cancer via an IFN-γ-dependent suppression of 15-hydroxyprostaglandin dehydrogenase. Front. Immunol. 13, 932412 (2022).
26. Igalouzene, R. et al. SMAD4 TGF-β-independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation. J. Clin. Invest. 132, e151020 (2022).
27. Kowdley, K. V.; Gochanour, E. M.; Sundaram, V.; Shah, R. A.; Handa, P. Hepcidin signaling in health and disease: ironing out the details. Hepatol Commun. 5, 723-35 (2021).
28. Dolmatova, E. V.; Wang, K.; Mandavilli, R.; Griendling, K. K. The effects of sepsis on endothelium and clinical implications. Cardiovasc. Res. 117, 60-73 (2021).
29. Parikh, A.; Stephan, A. F.; Tzanakakis, E. S. Regenerating proteins and their expression, regulation, and signaling. Bio. Concepts. 3, 57-70 (2012).
30. Qi, Z. et al. REG/Reg family proteins: mediating gut microbiota homeostasis and implications in digestive diseases. Gut Microbes 17, 2568055 (2025).
31. Cao, Y.; Tian, Y.; Liu, Y.; Su, Z. Reg3β: a potential therapeutic target for tissue injury and inflammation-associated disorders. Int. Rev. Immunol. 41, 160-70 (2021).
32. Yao, A.; Huang, C.; Wang, X.; Zhou, R.; Hao, W.; Lin, Q. The Reg protein family: potential new targets for the treatment of inflammatory bowel disease and colorectal cancer. Front. Gastroenterol. 3, 1386069 (2024).
33. Cash, H. L.; Whitham, C. V.; Behrendt, C. L.; Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-30 (2006).
34. Miki, T. et al. RegIIIβ promotes Salmonella Typhimurium colonization of the gut in the early-stage gastrointestinal infection by enhancing flagella-driven locomotion. PLoS Pathog. 21, e1013665 (2025).
35. Lörchner, H. et al. Reg proteins direct accumulation of functionally distinct macrophage subsets after myocardial infarction. Cardiovasc. Res. 114, 1667-79 (2018).
36. Song, Z. et al. Progranulin plays a central role in host defense during sepsis by promoting macrophage recruitment. Am. J. Respir. Crit. Care Med. 194, 1219-32 (2016).
37. Luo, C.; Li, B.; Liu, L.; Yin, H. P.; Wang, M.; Liu, J. L. Transcriptional activation of Reg2 and Reg3β genes by glucocorticoids and interleukin-6 in pancreatic acinar and islet cells. Mol. Cell. Endocrinol. 365, 187-96 (2013).
38. Lin, C. C.; Cheng, P. Y.; Hsiao, M.; Liu, Y. P. Effects of RU486 in treatment of traumatic stress-induced glucocorticoid dysregulation and fear-related abnormalities: early versus late intervention. Int. J. Mol. Sci. 23, 5494 (2022).
39. Song, C.; Tian, X.; Gelehrter, T. D. Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. U S A. 96, 11776-81 (1999).
40. Bryson, B. L.; Junk, D. J.; Cipriano, R.; Jackson, M. W. STAT3-mediated SMAD3 activation underlies oncostatin M-induced senescence. Cell Cycle 16, 319-34 (2017).
41. Vodovotz, Y. et al. Increased mortality, blunted production of nitric oxide, and increased production of TNF-α in endotoxemic TGF-β1 transgenic mice. J. Leukocyte Biol. 63, 31-9 (1998).
42. Mccartney-Francis, N.; Jin, W.; Wahl, S. M. Aberrant toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β1 signaling pathway. J. Immunol. 172, 3814-21 (2004).
43. Lv, K. Y. et al. Deficiency of Smad3 results in enhanced inducible nitric oxide synthase-mediated hypotension in lipopolysaccharide-induced endotoxemia. J. Surg. Res. 187, 640-5 (2014).
44. Wang, R. H. et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2, 399-409 (2005).
45. Schaible, U. E.; Collins, H. L.; Priem, F.; Kaufmann, S. H. Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196, 1507-13 (2002).
46. Gomes-Pereira, S.; Rodrigues, P. N.; Appelberg, R.; Gomes, M. S. Increased susceptibility to mycobacterium avium in hemochromatosis protein HFE-deficient mice. Infect. Immun. 76, 4713-9 (2008).
47. Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47-57 (2015).
48. Mu, Q. et al. The role of iron homeostasis in remodeling immune function and regulating inflammatory disease. Sci. Bull. 66, 1806-16 (2021).
49. Wu, Q. et al. Hemojuvelin regulates the innate immune response to peritoneal bacterial infection in mice. Cell Discov. 3, 17028 (2017).
50. De Domenico, I. et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Investig. 120, 2395-405 (2010).
51. Zeng, C.; Chen, Q.; Zhang, K.; Chen, Q.; Song, S.; Fang, X. Hepatic hepcidin protects against polymicrobial sepsis in mice by regulating host iron status. Anesthesiology 122, 374-86 (2015).
52. Brandl, K.; Plitas, G.; Schnabl, B.; Dematteo, R. P.; Pamer, E. G. MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891-900 (2007).
53. Yan, A. W. et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96-105 (2011).
54. Wang, L. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 19, 227-39 (2016).
55. Gironella, M. et al. Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. Cancer Res. 73, 5682-94 (2013).
56. van Ampting, M. T. J. et al. Intestinally secreted C-Type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. Infect. Immun. 80, 1115-20 (2012).
57. Namikawa, K.; Okamoto, T.; Suzuki, A.; Konishi, H.; Kiyama, H. Pancreatitis-Associated Protein-III Is a novel macrophage chemoattractant implicated in nerve regeneration. J. Neurosci. 26, 7460-7 (2006).
58. Lörchner, H. et al. Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart. Nat. Med. 21, 353-62 (2015).
59. Cineus, R. et al.; TRR241 IBDome Consortium. The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis. Nat. Immunol. 26, 837-53 (2025).
60. Yang, Z. et al. BAF60C links nucleolar stress to β cell dysfunction in type 2 diabetes through controlling Reg3b mRNA decay. Dev. Cell 61, 976-94.e11 (2026).
61. Zhang, Z.; Jones, S.; Hagood, J. S.; Fuentes, N. L.; Fuller, G. M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272, 30607-10 (1997).
62. Schneider, C. A.; Rasband, W. S.; Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-5 (2012).
63. Ito, T. et al. Cell barrier function of resident peritoneal macrophages in post-operative adhesions. Nat. Commun. 12, 2232 (2021).
64. Glaros, E. et al. Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease. Nat. Commun. 16, 3430 (2025).
65. Wang, Y. et al. DOT1L drives endothelial‐to‐mesenchymal transition and fibrotic vascular remodeling via H3K79 methylation. Adv. Sci. 13, e15581 (2026).
66. Yu, Y. et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 136, 726-39 (2020).
67. Kaur, I. et al. Primary hepatocyte isolation and cultures: technical aspects, challenges and advancements. Bioengineering 10, 131 (2023).
